Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Report: New Jersey Heating Up for Biopharma Incubators and Innovation Spaces

9h biospace
The Institute for Life Science Entrepreneurship (ILSE) released a white paper highlighting life science incubator space and innovation trends in New Jersey. The report, entitled “Recent Advances in Laboratory and Innovation Space in New Jersey” profiles these efforts.
JLL

0
Vietnam is Southeast Asia’s new industrial powerhouse

2018-07-17 business.inquirer.net
HCM CITY — In the last 20 years Vietnam has switched from being an agricultural economy to one of the brightest manufacturing hotspots in Southeast Asia, according to the latest report from Jones Lang LaSalle.
ATB JLL

115
Oakmark Equity And Income Fund: Second Quarter 2018

2018-07-11 seekingalpha
The Equity and Income Fund earned 0.2% in the quarter, while the Lipper Balanced Fund Index, the Fund’s performance benchmark, gained 1.1%.
PM C.WSA DOV.WI NOV TEL CVS FNF BAC C.WS.B CHTR APY.WI GM.WS.A FNFV C.WS.A GM.WS.B GM.WS.C C.PRP DOV C.PRU GM ORCL C.PRS LBRDB BAC C C.PRL AAL C.PRJ C.PRK BHGE COMM MA ARNC C.PRG TWC LBRDK C.PRC BHI C.PRPCL CGBBW OCLCF JLL LBRDA FL APY GM.WSB UNH

0
A Single Parking Space in Hong Kong Has Sold for $765,000 - Bloomberg

2018-07-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JLL NYTAB

0
A single parking space in Hong Kong has sold for $765,000

2018-07-07 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
JLL NYTAB

0
A Single Parking Space in Hong Kong Has Sold for $765,000

2018-07-06 theedgemarkets
The market for parking spaces is hotter than ever as a single spot in a luxury development in Kowloon’s Ho Man Tin district changed hands for a record HK$6 million ($765,000).
JLL NYTAB

0
5 Reasons to Snap Up CBRE Group (CBRE) Stock Right Away

2018-07-04 zacks
CBRE Group Inc. (CBRE - Free Report) offers a broad range of real estate products and services, and has extensive knowledge of domestic and international real estate markets. The company’s market-leading position will help it to capitalize on commercial real estate tailwinds. In June, the company announced the acquisition of procurement and facilities management solutions provider — FacilitySource, LLC — from Warburg Pincus.
VONOY CBG BLT BHP BHPBF BBL JLL VNNVF BHP BHPLF 0012 CBRE

0
Qatar fund buys Sahara-owned Plaza Hotel in New York for $600 million

2018-07-04 livemint
New York: The Plaza Hotel, one of New York’s most iconic buildings in which Subrata Roy-led Sahara India group has majority stakes, has been fully acquired by a Qatar government-owned fund for about $600 million, according to a media report on Wednesday.
JLL

2
5 Reasons to Invest in Jones Lang LaSalle (JLL) Stock Now

2018-07-02 zacks
Jones Lang LaSalle (JLL - Free Report) , better known as JLL, has a wide range of product and services and makes strategic investments to capitalize on market consolidations. Further, the company’s robust balance sheet, with a manageable debt position, is encouraging. Moreover, a positive trend in estimate revisions reflects optimism over the company’s earnings growth prospects. Over the last 30 days, the Zacks Consensus Estimate for JLL’s current quarter and 2018 earnings have moved up 3.
VONOY NMRK CIG JLL CIGI

1
No RERA impact? India moves up a spot to 35th on real estate transparency index

2018-06-29 livemint
Mumbai: India has moved up just one spot in the global real estate transparency index from 36 in 2016 to 35 in 2018, despite the implementation of the Real Estate (Regulation And Development) Act or RERA, according to a report by real estate advisory firm Jones Lang LaSalle Inc. (JLL).
JLL

1
Apartments only 1.7-pct of Colombo’s living units

2018-06-26 lankabusinessonline
Jun 26, 2018 (LBO) – Contrary to popular perception, apartments currently account for only 1.7 per cent of Colombo’s residential facilities despite the scarcity of land to cater to rapid urbanisation, an industry leader has disclosed.
JLL

9
James Howard Kunstler?!

2018-06-25 seekingalpha
Ahead now, I think you'll see the big nations shrink back into their own corners of the world. I'm not saying we'll see no international trade, but it will be nothing like the conveyer-belt from China to Wal-Mart (NYSE:WMT) that we've known the last few decades. And the prospects for conflict are very, very high.
JLL WMT

1
Luisenpark Berlin-Mitte: cultured urban living right in the heart of Berlin

2018-06-25 scmp
A new residential quarter between two of Berlin's most iconic squares puts the best of Germany's capital at your feet.
JLL

2
Office REITs: Time To Focus On Secondary Markets

2018-06-24 seekingalpha
It would be a good idea to shift the allocation in your portfolio from Class A Primary markets to Secondary markets and both Class A and Class B properties.
CUZ TIER JLL

22
CBRE Group Expands in Israel, to Buy Stake in Ramot Group

2018-06-21 zacks
CBRE Group Inc. (CBRE - Free Report) has announced to acquire a majority interest in Israel-based facilities management provider, Ramot Group. Terms of the deal have not been undisclosed yet. The deal, subject to customary regulatory approvals, is likely to be completed by third-quarter 2018. Notably, Ramot Group has been working with CBRE Group since 2009 and providing services to CBRE Group’s Israel-based corporate clients.
VONOY CBG CIG JLL CIGI CBRE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 48020Q107